Finance

Beta
Lists
RMTI:NASDAQ
Rockwell Medical Inc
$0.66
-4.72%
(-0.033) 1D
$0.66
-0.50% (-0.0033)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMTI...
Open
$0.68
High
$0.69
Low
$0.64
Mkt. cap
26.23M
Avg. vol.
293.83K
Volume
421.00K
52-wk high
$2.10
52-wk low
$0.64
EPS
-$0.15
Beta
1.58
Shares outstanding
39.47M
No. of employees
157
Open
$0.68
High
$0.69
Low
$0.64
Mkt. cap
26.23M
Avg. vol.
293.83K
Volume
421.00K
52-wk high
$2.10
52-wk low
$0.64
EPS
-$0.15
Beta
1.58
Shares outstanding
39.47M
No. of employees
157
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to RMTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RMTI in the last 3 months.
Highest
Current $0.66
$4.00 (+501.96%)
Average
$3.00 (+351.47%)
Lowest
$2.00 (+200.98%)
News stories
From sources across the web
Profile
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease. The company's primary customers are dialysis providers. Wikipedia
About Rockwell Medical Inc
CEO-
Employees157
Founded1996
HeadquartersWixom, Michigan, United States
SectorMedical device
Websiterockwellmed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.07M
15.93M
18.35M
17.34M
Cost of goods sold
13.57M
13.66M
14.47M
14.44M
Cost of revenue
13.57M
13.66M
14.47M
14.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.85M
3.86M
4.28M
4.38M
Operating expense
3.85M
3.86M
4.28M
4.38M
Total operating expenses
17.42M
17.51M
18.74M
18.82M
Operating income
-1.35M
-1.58M
-398.00K
-1.48M
Other non operating income
-
-
-
-
EBT including unusual items
-1.49M
-1.75M
-554.00K
-1.60M
EBT excluding unusual items
-1.56M
-1.81M
-640.00K
-1.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.49M
-1.75M
-554.00K
-1.60M
Net profit margin
-9.28%
-11.01%
-3.02%
-9.26%
Earnings per share
-
-
-
-
Interest and investment income
69.00K
55.00K
44.00K
37.00K
Interest expense
-276.00K
-285.00K
-286.00K
-282.00K
Net interest expenses
-207.00K
-230.00K
-242.00K
-245.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-786.00K
-1.04M
148.00K
-969.00K
Gain or loss from assets sale
3.00K
-1.00K
1.00K
178.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer